mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |